Perrigo Company (PRGO) 201.50 $PRGO Will Teva Manage To

Perrigo Company (PRGO) 201.50 $PRGO

Will Teva Manage To Complete The Takeover Of Mylan?
Emerging Equities - at Seeking Alpha - Wed Apr 22, 4:44PM CDT

PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), ASPX: 100.79 (+0.09)

Don't Cash In On Perrigo Yet, Upside Still Possible
Value Hawk - Seeking Alpha - Wed Apr 22, 4:27PM CDT
Summary: We recommend a sell for Perrigo Company (NYSE: PRGO ) with two triggers based on the possible scenarios. First, if Perrigo's price falls to $185, we recommend selling to protect significant gains from recent M&A conversations. On the...
PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Perrigo Rises 4.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Apr 22, 3:57PM CDT
Perrigo (NASDAQRGO) traded in a range yesterday that spanned from a low of $194.85 to a high of $202.27. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $200.37 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PRGO: 201.50 (+8.68)

Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:11PM CDT
Teva (TEVA) made an offer to acquire Mylan (MYL) for $82 per share in a deal that would create a powerhouse of generics with revenues of more than $30 billion.
ACT: 295.22 (+0.69), PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 12:18PM CDT
The following Perrigo (PRGO) conference call took place on April 22, 2015, 05:00 AM ET. This is a transcript of that earnings call:
PRGO: 201.50 (+8.68)

Mylan preparing new bid for Perrigo
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:47AM CDT

PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan
at The Street - Wed Apr 22, 8:46AM CDT
Teva has a path to complete the deal.
PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:00AM CDT
Perrigo Company's third-quarter fiscal 2015 earnings of $1.85 per share beat the Zacks Consensus Estimate of $1.80.
BIIB: 423.57 (+1.46), PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Downgrade Alert for Perrigo (PRGO)
Comtex SmarTrend(R) - Wed Apr 22, 7:10AM CDT
Perrigo (NASDAQRGO) was downgraded from Buy to Hold at Stifel today. The stock closed yesterday at $192.82 on volume of 6.0 million shares, above average daily volume of 2.1 million. Perrigo (NASDAQRGO) is currently priced 4.5% above its average consensus analyst price target of $184.17. The stock should discover initial support at its 50-day moving average (MA) of $166.96 and subsequent support at its 200-day MA of $157.16.
PRGO: 201.50 (+8.68)

Perrigo reports FQ3 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:28AM CDT

PRGO: 201.50 (+8.68)

Wall Street Breakfast: China Shares Extend Bull Run
Wall Street Breakfast - at Seeking Alpha - Wed Apr 22, 5:30AM CDT

PRGO: 201.50 (+8.68), BX: 41.76 (+0.04), SNE: 32.35 (+1.47), GOOG: 539.36 (+5.39), NOV: 53.93 (+0.80), YHOO: 43.97 (-0.52), SPY: 210.63 (+1.03), RIG: 16.85 (-0.18), S: 5.08 (+0.10), CMG: 641.23 (-51.29), FOXA: 34.04 (+0.09), GOOGL: 549.18 (+6.26), TMUS: 34.09 (+0.74), TWC: 149.64 (-2.36), MYL: 72.40 (-1.67), DIS: 107.94 (+0.26), PXD: 172.93 (-0.64), QQQ: 108.65 (+0.59), ARMH: 54.07 (+0.47), TEVA: 63.01 (-1.15), VZ: 49.57 (+0.40), CMCSA: 58.76 (-0.08), EPD: 33.35 (-0.29)

Update - Perrigo's Rejection Of Offer Gives Mylan 5 Strategy Options
Jordan Flannery - at Seeking Alpha - Tue Apr 21, 11:01PM CDT

PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Perrigo unanimously rejects Mylan bid
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:53PM CDT

PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67)

Perrigo beats by $0.07, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 3:23PM CDT

PRGO: 201.50 (+8.68)

Perrigo Company plc Reports Record Fiscal Third Quarter Net Sales, Adjusted Net Income, Adjusted Margins, And Operating Cash Flow
PR Newswire - Tue Apr 21, 3:03PM CDT
Third Quarter FY 2015 Highlights:
PRGO: 201.50 (+8.68)

Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan
PR Newswire - Tue Apr 21, 3:02PM CDT
Perrigo Company plc ("Perrigo" (NYSE: PRGO; TASE) today announced that its Board of Directors has unanimously rejected the unsolicited Proposal (the "Proposal" from Mylan NV ("Mylan" (NASDAQ: MYL), disclosed April 8, 2015, to acquire all of the outstanding shares of Perrigo for $205.00 per share. Following a thorough review, advised by its financial and legal advisors, the Board unanimously concluded that the Proposal substantially undervalues the Company and its future growth prospects and is not in the best interests of Perrigo's shareholders.
PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67)

Why Mylan NV Is Suddenly in the Driver's Seat
Sean Williams, The Motley Fool - Motley Fool - Tue Apr 21, 2:42PM CDT
Source: Teva Pharmaceutical, Facebook. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of...
PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Buyers Prop Up Nasdaq; Chipotle Rises Ahead Of Earnings
at Investor's Business Daily - Tue Apr 21, 1:49PM CDT
Stocks were mixed with just over one hour left in Tuesday's session. The Dow Jones industrial average and S&P 500 gave back early gains, but the Nasdaq hung in there, buoyed by strength in security software stocks. The Dow lost 0.3%, weighed down by...
PRGO: 201.50 (+8.68), CYBR: 65.53 (-0.84), MYL: 72.40 (-1.67), SBNY: 135.17 (-1.18), PANW: 153.87 (-0.50), UA: 82.27 (-1.25), CUDA: 45.71 (-0.08), CMG: 641.23 (-51.29), DD: 71.44 (+0.75), TEVA: 63.01 (-1.15), FTNT: 38.07 (-0.01)

Avoid Mylan And Perrigo As One Of Their Respective Buyout Offers Will Likely Disappear As Teva Pharmaceuticals Enters The Ring
Jordan Flannery - at Seeking Alpha - Tue Apr 21, 11:59AM CDT

PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15)

Teva Bids $40 Billion For Mylan, But May Need More
at Investor's Business Daily - Tue Apr 21, 10:35AM CDT
Israeli drug giant Teva Pharmaceutical Industries (TEVA) made its long-awaited bid for competitor Mylan on Tuesday, offering $82 a share, or $40.1 billion. Both stocks rose on the news. Teva's proposal, half cash and half stock, was unsolicited by...
PRGO: 201.50 (+8.68), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), MNTA: 18.62 (+0.56), NVS: 103.45 (-0.62)